MFS
NTLA icon

Mirabella Financial Services’s Intellia Therapeutics NTLA Stock Holding History

Mirabella Financial Services’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-12,335
Closed -$376K – 657
2023
Q4 		$376K Buy
+12,335
New +$355K 0.05% 253
2023
Q1 		– Sell
-7,308
Closed -$255K – 536
2022
Q4 		$255K Buy
+7,308
New +$347K 0.02% 278

Other funds holding NTLA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Mirabella Financial Services's NTLA Position: Q1 2024 in Review

Mirabella Financial Services sold out of Intellia Therapeutics (NTLA) in Q1 2024, closing a stake of 12,335 shares — an estimated $376K sold.

Mirabella Financial Services first reported a position in NTLA in Q4 2022 and held it in 2 quarters. The position peaked at $376K in Q4 2023. 284 funds tracked by Wall St. Rank hold NTLA as of Q1 2024.

  • Mirabella Financial Services reported no remaining Intellia Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Mirabella Financial Services sold 12,335 Intellia Therapeutics shares in Q1 2024, an estimated $376K.
  • Mirabella Financial Services first reported a position in Intellia Therapeutics in Q4 2022 and held it in 2 quarters.
  • Mirabella Financial Services's Intellia Therapeutics position peaked at $376K in Q4 2023.
  • 284 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q1 2024.

Based on Mirabella Financial Services's 13F filing for Q1 2024, filed 15 May 2024.